Similar patterns of cognitive and motor deficits have been widely reported from manganese exposures in welding, metallurgical and chemical industry workers. A risk assessment was performed based on studies reported in the literature, extending some earlier work, and deriving new estimates of exposure response and excess risk. Many investigations of manganese neurological effects in humans have insufficient information to derive an exposure response; however, findings from a chemical manufacturer, two smelter and two welder populations permitted application of the benchmark dose procedure for continuous end-points. Small particles and aggregates of condensation fume (condensing vaporized metal, <0.1 mm in diameter) appear to have a higher potency per unit mass than larger particles from dusts (>1.0 mm). Consideration was given to long-term effects of continuous low exposures that instead of producing increasing toxicity attain a steady-state condition. Impairment was defined as excursions beyond the 5th percentile in a normal population and the concentrations of manganese predicted to result in 1% excess prevalence of impairment over different time periods were calculated. Over five years, exposures resulting in 1% excess prevalence of impairment (for purposes of discussion) were in the vicinity of 10 mg/m 3 for manganese fume and 25 mg/m 3 for larger particle dusts.
Introduction
Blood levels of manganese (Mn), an essential nutrient, are heavily regulated to accommodate widely varying food intake and interacting iron metabolism. The routine physiologic control of Mn is mostly exercised in the gastrointestinal tract and liver, while inhaled manganese appears to be much less well managed (Andersen et al., 1999) . The metabolic control of Mn has been examined in detail using physiologically based pharmacokinetic (PBPK) models (Ramoju et al., 2017) .
There is considerable epidemiological evidence of homeostatic Mn regulation. Quebec smelter workers showed a negative dose-rate effect where increasing air levels of Mn produced less than proportional increases in a) blood levels (Park et al., 2014a) and b) neurobehavioral effects (Park et al., 2014b) . For the neurobehavioral end-points examined in Quebec smelter workers, such as those measured by the Luria Motor scale, recent duration of exposure (e.g., prior five years) was as good as, or superior to, the corresponding recent Mn cumulative exposure metric in predicting impairment using a detailed retrospective exposure assessment. In South African smelter workers, a strong attenuation of neurobehavioral effects with increasing cumulative Mn exposure suggests a role for homeostatic controls (Myers et al., 2003b; Thompson and Myers, 2006) . While in humans there is a dose-response relationship with duration of exposure to airborne Mn at physiologically-regulated blood levels, lower exposure concentrations are also potentially hazardous. These considerations argue against a special role for short-term high exposures, although delays in physiological regulatory responses to rapidly changing exposure levels could become important in uptake and distribution.
In response to the growing large body of evidence concerning neurobehavioral impairment resulting from manganese occupational and ambient environmental inhalation exposures, several risk assessments have been conducted using epidemiologic data collected on welders and other Mn-exposed worker populations. Benchmark dose (BMD) analyses were applied using the Roels et al. (1992) data from alkaline battery workers and from a cohort of bridge welders . Summaries of these risk assessments are presented here. In addition, studies of smelter workers in Quebec (Mergler et al., 1994) and South Africa (Myers et al., 2003b) , and welding trainees (Laohaudomchok et al., 2011) provided additional opportunities for risk assessment. This work assembles risk estimates from the studies with sufficient retrospective exposure assessment and evaluation of neurobehavioral outcomes to support a quantitative risk assessment. Summary estimates of risk are presented along with discussion of issues unique to neurobehavioral end-points in protecting workers as previously raised by Park et al. (2006) .
Benchmark dose calculations for risk assessment
BMD analyses require defining an impairment threshold for the outcome under study. This is often the 5th percentile of poor performance in a normal or unexposed population (used for the present analysis) or impairment quantified as a standardized or other evaluation score determined by clinical consensus. Also required is specification of a maximum acceptable increment in the attributable risk of impairment (Bailer et al., 1997; Crump, 1995) , usually ranging from 0.1% to 10%. Considerations of homeostatic regulation imply that cumulative exposure may not be an optimum metric in linear models of exposure response (Clewell et al., 2003; Park et al., 2014a Park et al., , 2014b Thompson and Myers, 2006) . Other metrics related to body burdens of Mn have been used in estimating dose-response for neurobehavioral outcomes (Park et al., 2014a) . In addition this risk assessment considers recent Mn exposures, defined as exposures in the prior 5 years, as a possible appropriate metric. However, most plausible metrics are correlated (e.g., cumulative exposure or burdens with various half-lives) and most population observations have been for relatively short time periods (compared to a 45 year working lifetime) making the choices of an appropriate metric and model specifications difficult for predicting long-term effects. One important possibility with some empirical support is that, for a given fixed low Mn exposure concentration, a steady-state or maximal response is attained after some time interval much less than 45 years. In the Quebec smelter study, there was weak support favoring burden metrics with half-lives on the order of a few years suggesting that impairment reflected relatively recent exposure, not cumulative exposure over a lifetime (Park et al., 2014b ). The PBPK model simulation work of Ramoju et al. (2017) observed attainment of steady-state Mn concentrations in the globus pallidus after about 1 year at airborne concentrations of 300 mg/m 3 in battery manufacturing workers. In this situation, it would be inappropriate to linearly extrapolate an observed response based on cumulative exposure over several years to a 45 year working life. All of the risk assessments utilizing battery worker data reported by McClure and Odin (1998) used average current Mn exposure intensity as the predicting metric, implicitly assuming a steady state response, attained in this case over a 5 year period. et al. (1999) produced an estimate of the lowest observable adverse effect level (LOAEL) for Mn-induced neurobehavioral deficits in ferroalloy workers. The 97.7 mg/m 3 LOAEL was based on the mean cumulative exposure and mean duration (11.5 years) of the mid-level exposed subpopulation. This estimate was dependent on choices made in stratifying the population on exposure (Bailer et al., 1997; Clewell et al., 2003) . It was also affected by the history of rapidly declining Mn air concentrations in this industry (2 to 5 fold reductions over 10 years), raising the possibility of irreversible effects sustained from earlier higher exposures. Roels et al. (1992) conducted a semi-quantitative risk assessment on their data of alkaline battery production workers and low-exposed chemical workers. They concluded that a lifetime integrated exposure of 1200 mg/m 3 -yr respirable Mn resulted in "slight neurofunctional changes in a significant proportion of exposed subjects." In this study population with an average duration of exposure of 5.3 years, the lifetime integrated exposure level corresponded to an average level of 225 mg/m 3 . McClure and Odin (1998) conducted a BMD analysis of, and summarized previous work on, the Roels et al. (1992) data on eyehand coordination. The exposure metric used was a worker's lifetime average air concentration of either total or respirable Mn. The average exposure levels for respirable Mn corresponding to maximum acceptable levels of increased risk of impairment were calculated making various exposure-response modeling assumptions (Table 1 ). There was considerable agreement across investigators and modeling approaches in estimating the benchmark dose for a 10% additive increase in risk of eye-hand coordination impairment above the 5th percentile threshold in relation to respirable Mn. The estimates ranged from 113 to 183 mg/m 3 (McClure and Odin, 1998) . BMD estimates were also reported for additive excess risk levels of 5% down to 0.1% using three modeling strategies. Increased variability in risk estimates at the lower exposure concentrations was observed. For example, for a 0.5% risk increment in impaired eye-hand coordination, the BMDs ranged . Clewell et al. (2003) also analyzed data from a low-exposed population of chemical manufacturing workers (Gibbs et al., 1999) across five endpoints using different modeling approaches for a total of 13 estimates based on current exposure. The BMD results for a 10% impairment increment ranged from 275 mg/m 3 (reaction time) to 3980 mg/m 3 (tap time, continuous). Several of the outcomes were unable to be analyzed due to negative associations. The mean lower 95% confidence limit for the five endpoints Table 1 Risk assessments for manganese and impaired eye-hand coordination, using Roels et al. (1992) (averaging models within endpoints) was 190 mg/m 3 , about the same as that calculated by Roels et al. (1992) . Park RM et al. (2006) conducted an exploratory risk assessment for neurobehavioral outcomes in welders working in confined spaces during construction of bridge piers originally reported by Bowler et al. (2007) . Park et al. (2009) subsequently conducted a risk assessment of the same workers using more detailed work histories and a more complete exposure assessment (Table 2) . Neurobehavioral assessment data were available for more than 80% of the welders employed for up to 2 years on this bridge construction project involving work in confined spaces. Exposures were estimated from compliance sampling including 116 mostly full-shift or half-shift personal breathing zone samples and 43 area samples. The bridge welders showed statistically significant negative performance associations with burden or cumulative burden metrics over a 2 year period in five of 10 measures examined: Design Fluency (one-tailed p-value = 0.014, for exposure metric regression coefficient), Working Memory (WAIS III) (p = 0.015), Verbal IQ (p = 0.015), Verbal Comprehension (p = 0.016) and Stroop Color-Word (p = 0.045). The BMD estimates for a 5% increase in impairment ranged from 27 to 151 mg/m 3 using the 1st, 5th and 10th percentile of normal to define impairment (Park et al., 2009) (Table 2 ). The deficits observed in these standardized neurobehavioral tests in bridge welders corresponded to significant levels of symptoms: 63% of welders had clinical depression on the Beck Depression Inventory (BDI), and 80% had clinical elevation in anxiety (Bowler et al., 2007) .
Published risk assessments
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Materials and methods
Description of published studies used for new assessments
From the Mergler et al. (1994) study of Quebec smelter workers three neurobehavioral end-points (Luria Motor Scale, Trail Making A and Trail Making B) were used for BMD excess risk calculations. The original response data, as T-scores, were available and the exposure metrics used were those with the best statistical model fit in estimating the exposure response (Park et al., 2014b) ; these were burden metrics with half-lives based on estimated exposure levels of "small" respirable Mn. Applying the estimated exposure response for a series of constant exposure levels over a 45 year working life using a benchmark dose procedure as described previously (Park et al., 2006) yielded corresponding risk estimates for the Luria Motor and Trail Making outcomes.
From the South African smelter workers study of Myers et al. (2003b) published regression model findings for both cognitive and motor outcomes in relation to cumulative Mn exposure provided a basis for risk assessment. The calculation of BMD estimates depended on normative data (expected means and standard deviations) for the reported outcomes which were provided by the study investigators [personal communication, Dr. Jonny Myers, 10/16/16] . For several of the outcomes the investigators observed the exposure response to be non-linear with an initial rapid change at low levels of cumulative exposure (Myers et al., 2003b; Thompson and Myers, 2006) . The present risk assessment used the exposure response reported in the lowest cumulative exposure stratum (<1.3 mg/m 3 -yr) which is closer than the higher strata to worker exposure levels of concern. Applying the reported regression estimates of exposure response for the eight outcomes analyzed for the South African smelter workers in the benchmark dose procedure produced risk estimates for 45 year exposures. From the San Francisco bridge welders study, in addition to the five cognitive outcomes on which a published risk assessment was based (Park et al., 2009) , eight other outcomes, all motor-related, were evaluated using regression results provided by the original investigators [personal communication, Drs. Vihra Gocheva and Rosemarie Bowler, 10/28/16] ( Table 4 ). The regression analyses predicted motor outcomes in relation to cumulative Mn exposure (over the 2 year project), controlling for age, years of education and race, and corresponding risk estimates were calculated as previously performed for the five cognitive outcomes.
In a study of welding trainees from a Boston-area union (Laohaudomchok et al., 2011) response time, finger tapping, handwriting stability and Profile of Mood States (POMS) were evaluated. Response time was measured using the Continuous Performance Test [CPT, Neuro-behavioral Evaluation System 3; (Letz, 2000; Letz et al., 2003) ]. Using linear regression those investigators found a significant increase in response time with welding exposure (b = 0.71 ms/(mg/m 3 -h), SE b = 0.22). For the calculation of excess risk here, it was assumed that the CPT is approximately normally distributed in the general population and that the population standard deviation (SD) (unavailable) was close to that observed in the trainee group (e.g., 57 ms) although, in the latter, there could be additional variance due to the exposure effect. The population was exposed for only 1-5 years and excess risk was calculated for only a 15 year period rather than the usual working lifetime of 45 year because of the uncertainty on long-term cumulative effects (Table 4 ). The finger-tapping exposure-response regression result was very imprecise in this welder population with low exposures (median: 12.9 mg/m 3 PM 2.5 Mn) despite a statistically significant overall group performance deficit on finger tapping, and the handwriting and POMS outcomes posed challenges in terms of background rates, normal variability and defining impairment; these outcomes were not included in this risk assessment.
Alternate risk assessment assumptions
Taking into account possible reversible components and attainment of steady-state levels of impairment with constant low exposure, the estimated fixed concentrations conferring 1% excess risk were calculated for the two smelter and the two welder populations corresponding to five rather than 45 years of exposure. For the chemical worker study, the exposure metric was average airborne concentration (not cumulative) and the duration of employment was about 5 years; therefore the reported risks were for the equivalent of 5-year cumulative exposures. 
Data analysis
All calculations were performed in SAS (SAS, 1999) using macros constructed for specific benchmark dose estimations.
Results
From the Quebec smelter study, excess risks of 5% or 1% for the Luria Motor Scale corresponded to 45 year constant exposures of 21 or 5.5 mg/m 3 , respectively, for impairment defined as scores departing more than 1.64 SD from the mean ( Table 3 ). The selected exposure metric used for Luria Motor Scale calculations assumed that the Mn blood burden had a half-life of 5 years and a linear dependence on exposure intensity that was truncated above 25 mg/m 3 (to address homeostasis); excess risk was evaluated at age 65 at which point the maximum burden would have occurred. The mean exposure averaged over time for this smelter population (Table 3 ). In the South African smelter study for an excess risk of 1%, the estimated 45 year exposures over eight outcomes ranged 4-12 mg/m 3 inhalable Mn (Table 4 ). These estimates assumed that the exposure response observed in the low cumulative exposure stratum can be used to predict an accumulating risk over 45 years. For the motor outcomes in the bridge welder study, risks of 1% accruing from a 2 year period corresponded to Mn exposures ranging 13-89 mg/ m 3 (Table 4; discrepancy between Tables 2 and 4 for the outcomes reported in Park et al. (2009) arises because the SD used to define impairment in Table 2 was derived from the regression residual standard error while in Table 4 the normative score SD was utilized). In the apprentice welders, increased response times (by 1.64 SD) with an excess risk of 1% corresponded to a 15 year exposure to 1.0 mg/m 3 Mn (PM 2.5) (Tables 3 and 4) .
Five year steady-state risk assessment
For the Belgian battery chemical workers, whose average duration of exposure was about 5 years, the 5-year risks corresponding to different levels of current exposure were those previously calculated (McClure and Odin, 1998) . From the findings in the South African smelter study (Myers et al., 2003b) excess risks for cumulative exposures over 5 years were calculated in the same manner as for 45 years yielding substantially higher Mn levels for 1% excess risk (by a factor of 45/5) (Table 4) . Similarly, estimates were calculated for the Quebec smelter workers, based on 5-year steady state exposures (Park et al., 2014b) . For the San Francisco bridge welders, the estimates of exposure for 2-year (observed employment duration on bridge piers at time of study) and 5-year effects were calculated based on reported cognitive outcome regression results (Park et al., 2009 ). For outcomes predicted by Mn burdens with small half-lives, e.g., the Design Fluency with 90 day half-life, the exposure levels causing a specified impairment over 2 or 5 years would be similar. For the bridge welder results on motor performance, the non-dominant hand findings were used because they were consistently stronger and displayed higher statistical significance. (The smaller effects in the dominant hand may represent a) neurological compensation or b) higher vulnerability of less used pathways in the brain [personal communication, Dr. Vihra Gocheva, 11/1/16] ). Finally the 1% excess prevalence of impaired response time in apprentice welders (Laohaudomchok et al., 2011) , calculated over 5 years gave an estimate of 2.9 mg/m 3 Mn (Table 4) .
Over 5 years, 1% excess risk of impairment appears to result from lower exposures to welding fume compared to the Belgian chemical and South African smelter exposures with larger airborne particulate (Table 4) ; in the South African smelter study, inhalable air sampling was conducted across homogeneous exposure zones covering raw material handling, electric furnace operation and crushing of cast manganese (Myers et al., 2003a) . In the case of the Quebec smelter workers, the exposure metric used was "small respirable" particles derived from location proximity to electric furnace operation which produce a Mn fume with very small particle size. The 1% excess risk Mn concentrations for the Quebec smelter workers were similar to the welding populations. Although the dust-exposed workers, for which higher Mn concentrations were predicted for 1% excess risk, were evaluated primarily for motor-related effects, in the welding populations both motor and cognitive end-points appear to have similar responses, at lower concentrations.
Discussion
Reversibility and other concerns
In considering an exposure limit for occupational exposure to manganese, several issues must be addressed relating to neurobehavioral impairment: acceptable risk, metabolic regulation of this essential dietary nutrient, and the derivation of appropriate exposure-response relationships. Neurobehavioral health effects that are adverse and measurable and would qualify as clinical impairment, such as depression, anxiety, memory loss or motor deficits, are appropriate end-points for consideration. Although the research literature provides clear evidence of adverse neurobehavioral effects of sustained low air Mn concentrations (<0.2 mg/m 3 ), there are important unknowns such as a) the extent to which irreversible, cumulative changes are occurring, b) role of particle size, c) particle chemical form and solubility. Some apparent reversibility may actually be instances of complex compensation or accommodation imposing other burdens or adverse consequences (Martinu and Monchi, 2013; Mohr et al., 2016) . Several investigations have examined aspects of reversibility (Bouchard et al., 2007a (Bouchard et al., , 2007b (Bouchard et al., , 2008 Bowler et al., 2011; Huang et al., 1998; Josephs et al., 2005) . Some reversibility was observed by Bouchard et al. (2007a) in all three areas: neuromotor, cognitive and psychiatric outcomes. Reversibility, here, pertains to behavioral manifestations and may not reflect reversal of underlying neurological damage. One issue is how workers should be protected from exposures resulting in reversible impairment, when experienced over periods less than a working lifetime.
This risk assessment examines end-points that could be interpreted as assessing both acute and chronic effects. No attempt was made to distinguish these, and the 5 year attainment period utilized tends to capture both acute and chronic contributions.
Risk assessment ultimately requires choosing a target excess risk. For illustration purposes, a target risk of 1% was selected. The risk assessments for multiple neurobehavioral end-points are summarized in Table 4 , presenting the reported or calculated cumulative effects of Mn exposure and equivalent estimates based on 5 year steady-state responses. These estimates of airborne Mn exposure concentrations represent levels at which a 1% excess risk of impairment is expected where impairment is defined on the 5th percentile in the normal population or at 1.64 SD from normal. If there were irreversible and cumulative effects from Mn exposure, then the estimated steady state related exposures in Table 4 would represent upper bounds for the maximum allowable exposure. If there are only reversible effects and a steady-state is attained after 2 years, for example, then higher corresponding Mn levels would result, as displayed for the San Francisco bridge welders (Table 4) .
Implications for risk management
For end-points evaluated in relation to small respirable Mn particulate, as for condensation fume, the exposure levels predicting 1% excess impairment ranged 2. Myers et al., 2003b) .
For Mn fume this is a factor of 2.0 lower than the threshold limit value (TLV) presented by the American Conference of Governmental Industrial Hygienists (ACGIH) (ACGIH, 2013) for "respirable particulate matter." Also specifying a two-tier occupational exposure limit, the ACGIH established a maximum level of 100 mg/m 3 for "inhalable particulate matter" which would include dusts above the 10 mm range, from non-welding and non-electric furnace operations, and which is a factor of 4 higher than the 1% excess risk dust levels shown here (a factor of 3 for inhalable Mn). At other target excess risks, e.g., 5% or 0.5%, the corresponding Mn exposures would be essentially proportional to the 1% risk estimates.
Summary
This risk assessment utilized estimates of exposure response derived from epidemiological analyses of occupationally manganese-exposed populations. It extended some earlier work while calculating new estimates of exposure response and excess prevalence of impairment. Impairment was defined as excursions beyond the 5th percentile in a normal population. Small particles and aggregates of condensation fume (condensing vaporized metal, <0.1 mm in diameter) appeared to have a higher potency per unit mass than larger particles from dusts (>1.0 mm) providing further support for a two-tiered approach previously adopted by ACGIH for establishing exposure limits to protect against adverse neurobehavioral effects. In considering an exposure limit, several issues were addressed relating to neurobehavioral impairment: acceptable risk, metabolic regulation of this essential dietary nutrient, and the derivation of appropriate exposure-response relationships for health effects that may be partially reversible, may attain maximal levels after prolonged exposures at moderate concentrations, and are responsive to homeostatic regulation. Although future investigations will enhance understanding of the mechanisms of Mn induced neurobehavioral effects, the currently available knowledge is sufficient for progress in risk assessment of public health significance.
